HR+ NSCLC More Common in Women; EGFR, KRAS More Common in HR+ NSCLC AJMC, 18 Sep 2023 Women were more likely to have hormone receptor–positive (HR+) non–small cell lung cancer (NSCLC) than men, and EGFR and KRAS…